Neurocrine Biosciences (NBIX) EPS (Diluted) (2010 - 2026)
Powered by 
Analysis
Neurocrine Biosciences (NBIX) EPS (Diluted) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.53 Bn | 625.77 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 442.27 Bn | 435.70 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 366.81 Bn | 359.67 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | 1.67 |
| 5 | Pfizer | 159.37 Bn | 147.67 Bn | 10.94 Bn | -0.04 |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | 0.33 |
| 7 | Revolution Medicines | 44.12 Bn | 44.12 Bn | - | -3.06 |
| 8 | Incyte | 25.49 Bn | 20.95 Bn | 1.57 Bn | 2.81 |
| 9 | United Therapeutics | 21.55 Bn | 18.89 Bn | 683.80 Mn | 7.27 |
| 10 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 1.39 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.39 |
| Mar 31, 2026 | 1.91 |
| Dec 31, 2025 | 1.50 |
| Sep 30, 2025 | 2.04 |
| Jun 30, 2025 | 1.06 |
| Mar 31, 2025 | 0.08 |
| Dec 31, 2024 | 0.99 |
| Sep 30, 2024 | 1.24 |
| Jun 30, 2024 | 0.63 |
| Mar 31, 2024 | 0.42 |
| Dec 31, 2023 | 1.46 |
| Sep 30, 2023 | 0.82 |
| Jun 30, 2023 | 0.95 |
| Mar 31, 2023 | -0.79 |
| Dec 31, 2022 | 0.90 |
| Sep 30, 2022 | 0.69 |
| Jun 30, 2022 | -0.18 |
| Mar 31, 2022 | 0.14 |
| Dec 31, 2021 | -0.07 |
| Sep 30, 2021 | 0.23 |